123 related articles for article (PubMed ID: 19275665)
1. Atheroprotective properties of pigment epithelium-derived factor (PEDF) in cardiometabolic disorders.
Yamagishi S; Matsui T; Nakamura K
Curr Pharm Des; 2009; 15(9):1027-33. PubMed ID: 19275665
[TBL] [Abstract][Full Text] [Related]
2. Anti-atherothrombogenic properties of PEDF.
Yamagishi SI; Matsui T
Curr Mol Med; 2010 Apr; 10(3):284-91. PubMed ID: 20236055
[TBL] [Abstract][Full Text] [Related]
3. Pigment Epithelium-Derived Factor: A Novel Therapeutic Target for Cardiometabolic Diseases and Related Complications.
Yamagishi SI; Matsui T
Curr Med Chem; 2018; 25(13):1480-1500. PubMed ID: 28595552
[TBL] [Abstract][Full Text] [Related]
4. Pigment epithelium-derived factor (PEDF) administration inhibits occlusive thrombus formation in rats: a possible participation of reduced intraplatelet PEDF in thrombosis of acute coronary syndromes.
Takenaka K; Yamagishi S; Matsui T; Nakamura K; Jinnouchi Y; Yoshida Y; Ueda S; Katsuki Y; Katsuda Y; Imaizumi T
Atherosclerosis; 2008 Mar; 197(1):25-33. PubMed ID: 17850801
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiological role of pigment epithelium-derived factor (PEDF) in hepatic disorders.
Yamagishi SI; Matsui T; Kawaguchi T; Sata M
Curr Med Chem; 2010; 17(19):1995-2000. PubMed ID: 20423314
[TBL] [Abstract][Full Text] [Related]
6. Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease.
Rychli K; Huber K; Wojta J
Expert Opin Ther Targets; 2009 Nov; 13(11):1295-302. PubMed ID: 19694500
[TBL] [Abstract][Full Text] [Related]
7. The effects of pigment epithelium-derived factor on atherosclerosis: putative mechanisms of the process.
Ma S; Wang S; Li M; Zhang Y; Zhu P
Lipids Health Dis; 2018 Oct; 17(1):240. PubMed ID: 30326915
[TBL] [Abstract][Full Text] [Related]
8. Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation.
Nakamura K; Yamagishi S; Matsui T; Yoshida T; Takenaka K; Jinnouchi Y; Yoshida Y; Ueda S; Adachi H; Imaizumi T
Am J Pathol; 2007 Jun; 170(6):2159-70. PubMed ID: 17525281
[TBL] [Abstract][Full Text] [Related]
9. Pigment epithelium-derived factor (PEDF): its potential therapeutic implication in diabetic vascular complications.
Yamagishi S; Matsui T; Nakamura K; Ueda S; Noda Y; Imaizumi T
Curr Drug Targets; 2008 Nov; 9(11):1025-9. PubMed ID: 18991613
[TBL] [Abstract][Full Text] [Related]
10. Pigment epithelium-derived factor (PEDF) and cardiometabolic disorders.
Yamagishi S; Matsui T
Curr Pharm Des; 2014; 20(14):2377-86. PubMed ID: 23844817
[TBL] [Abstract][Full Text] [Related]
11. Pigment epithelium-derived factor (PEDF) binds to caveolin-1 and inhibits the pro-inflammatory effects of caveolin-1 in endothelial cells.
Matsui T; Higashimoto Y; Taira J; Yamagishi S
Biochem Biophys Res Commun; 2013 Nov; 441(2):405-10. PubMed ID: 24161393
[TBL] [Abstract][Full Text] [Related]
12. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
Fujimura T; Yamagishi S; Ueda S; Fukami K; Shibata R; Matsumoto Y; Kaida Y; Hayashida A; Koike K; Matsui T; Nakamura K; Okuda S
Nephrol Dial Transplant; 2009 May; 24(5):1397-406. PubMed ID: 19042927
[TBL] [Abstract][Full Text] [Related]
13. A physiological approach for treating endometriosis by recombinant pigment epithelium-derived factor (PEDF).
Chuderland D; Hasky N; Ben-Ami I; Kaplan-Kraicer R; Grossman H; Shalgi R
Hum Reprod; 2013 Jun; 28(6):1626-34. PubMed ID: 23466670
[TBL] [Abstract][Full Text] [Related]
14. Pigment epithelium-derived factor, a noninhibitory serine protease inhibitor, is renoprotective by inhibiting the Wnt pathway.
He X; Cheng R; Park K; Benyajati S; Moiseyev G; Sun C; Olson LE; Yang Y; Eby BK; Lau K; Ma JX
Kidney Int; 2017 Mar; 91(3):642-657. PubMed ID: 27914705
[TBL] [Abstract][Full Text] [Related]
15. Pigment epithelium-derived factor improves metabolic derangements and ameliorates dysregulation of adipocytokines in obese type 2 diabetic rats.
Matsui T; Nishino Y; Ojima A; Maeda S; Tahara N; Yamagishi SI
Am J Pathol; 2014 Apr; 184(4):1094-1103. PubMed ID: 24530621
[TBL] [Abstract][Full Text] [Related]
16. Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes.
Amano S; Yamagishi S; Inagaki Y; Nakamura K; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2005 Jan; 69(1-2):45-55. PubMed ID: 15797260
[TBL] [Abstract][Full Text] [Related]
17. Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF.
Yamagishi S; Nakamura K; Ueda S; Kato S; Imaizumi T
Cell Tissue Res; 2005 Jun; 320(3):437-45. PubMed ID: 15846509
[TBL] [Abstract][Full Text] [Related]
18. Protective Role of PEDF-Derived Synthetic Peptide Against Experimental Diabetic Nephropathy.
Ishibashi Y; Matsui T; Taira J; Higashimoto Y; Yamagishi S
Horm Metab Res; 2016 Sep; 48(9):613-9. PubMed ID: 27214310
[TBL] [Abstract][Full Text] [Related]
19. PEDF in diabetic retinopathy: a protective effect of oxidative stress.
Zhu XF; Zou HD
J Biomed Biotechnol; 2012; 2012():580687. PubMed ID: 22570532
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of PEDF-transfected ADSCs on erectile dysfunction in a streptozotocin-diabetic rat model.
Lu J; Xin Z; Zhang Q; Cui D; Xiao Y; Zhuo J; Sun F; Xia S; Shao Y
Cell Tissue Res; 2016 Dec; 366(3):623-637. PubMed ID: 27655233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
